Michael Saylor’s Strategy Just Faced First Liquidity Test
MicroStrategy disclosed its first Bitcoin sale under Michael Saylor’s strategy, selling 32 BTC to fund preferred stoc...
Which Index Funds Have Lowest Capital Gains Distributions
Some index funds distribute fewer capital gains than others, which can reduce tax surprises and improve after-tax performance over time.
28,126 articles
Progressive Insurance Fell Today: What Investors Should Know
Progressive Insurance fell today as markets weighed mixed quarterly results. This article breaks down the numbers, ex...
Shareholders Received Amazing News From AMD's New Customer
AMD just struck a landmark deal with a global AI cloud leader. This article breaks down what the contract means for r...
Electrocore (ECOR) 2025 Earnings: Key Takeaways for Investors
Electrocore (ECOR) is navigating a pivotal year. This article dives into the 2025 earnings landscape, unpacking reven...
Three Reasons Micron Smart Before June 24 Earnings
As Micron prepares to report on June 24, three solid reasons could justify a closer look at MU. This guide breaks dow...
C2 Financial Bets on Nationwide Growth Push Amid Pullback
C2 Financial announced a nationwide expansion to reclaim its No. 1 wholesale ranking. The plan centers on AI upgrades...
Stock Market Today, March: AMD Rally on CPU Price Boost
A fresh rally in semiconductor names has investors buzzing about CPU pricing power and AI infrastructure demand. This...
Aehr Test Systems Stock Surges After Repeat Order
Aehr Test Systems stock jumped on Wednesday after a repeat order for automated wafer burn-in systems signaled growing...
Ramsey’s No Credit Score Debate: A Closer Look at the Truth
In 2026, Ramsey’s no credit score concept draws fresh scrutiny as lenders balance underwriting rules with consumer ac...
Hut 8 AI Pivot Spurs Canaccord Target Jump to $130 Today
Hut 8 is pivoting to AI data center infrastructure, prompting a Canaccord upgrade that nearly doubles the firm’s pric...
Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Investors Hated CoreWeave's Earnings, Could Worsen
CoreWeave delivered stronger top-line growth but a widening loss and cautious quarterly guidance. Investors reacted w...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status